Navigation Links
Biomedical Engineer and Quality Assurance Expert, Jeffrey P. Taub, Joins NDA Partners as Expert Consultant
Date:5/27/2020

NDA Partners Chairman Carl Peck, MD, announced today that Jeffrey Taub, a biomedical engineer with more than 25 years of experience in product design, development, and manufacturing of medical devices and combination products, has joined the firm as an Expert Consultant. His expertise includes quality assurance, including ISO 13485 and FDA QSR (21 CFR 820), risk-based product development (ISO 14971), design controls and design verification, human factors and usability (ISO 62366), and supply chain and CMO management.

Throughout his career, he has successfully designed, launched, and marketed more than a dozen medical devices including single and multichannel LVP infusion pumps, intraoral dental imaging systems, intravascular cooling systems, ultrasound imaging and ablation devices, an interferential pain management (TENS) product, a DNA sequencing sample prep instrument, and an RF ablation surgical cutting product.

Most recently, Mr. Taub served as Senior Technical Project Manager and Director of Product Development at Paramit Product Development. Prior to joining Paramit, he served as Vice President of Research and Development at Surgitech Surgical Technologies, Director of Device Engineering at Vital Therapies, Inc., and Senior Program Manager and Engineering Manager at BIT Group USA (formally Paragon MedSystems and California MedTech).

According to Dr. David Feigal, manager of NDA Partners’ medical device practice, “Mr. Taub’s experience in product design, development, and manufacturing, in addition to his expertise in quality assurance, risk-based product development, and design controls and verification, will bring significant benefits to our clients developing medical device and combination products. We are pleased to welcome him to NDA Partners.”

Mr. Taub earned his bachelor’s degree in biomedical engineering from Boston University’s College of Engineering.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle@ndapartners.com

Read the full story at https://www.prweb.com/releases/biomedical_engineer_and_quality_assurance_expert_jeffrey_p_taub_joins_nda_partners_as_expert_consultant/prweb17138004.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Medisend College Sends Biomedical Equipment to Zoe Geh Medical Center in Liberia
2. City of Fremont, Biomedical Manufacturing Network and BSMA to Collaborate to Advance the Bio-Pharma Industry in California
3. Boston Biomedical Presents New Preclinical Data at AACR 2017 Highlighting the Potential Role of Cancer Stemness Inhibition
4. Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk Partner to Innovate Healthcare IT for Chronic Disease
5. Boston Biomedical to Present Preclinical Data on Targeting Cancer Stemness at AACR 2017
6. Lovelace Biomedicals Advances in Toxicological Research to be Featured at the 56th Annual Meeting of the Society of Toxicology
7. Amarantus Enters into a Letter of Intent to Acquire Certain Biotechnology Assets from SeD BioMedical Inc.
8. Entest BioMedical Inc.s Zander Therapeutics Unit Announces Publication of Canine Cellular Immunotherapy Patent Application for Treating Cancer in Dogs
9. Entest BioMedical Inc.s Subsidiary Zander Therapeutics Makes Key Additions to Management Team as the Company Prepares to Move Forward in the $63 Billion Veterinary / Pet Market Niche
10. Data4Cures AI-Powered Biomedical Intelligence Cloud Features New Tools for Multidimensional Disease Mapping and Immune-Oncology Research
11. Boston Biomedical Announces Orphan Drug Designation for Napabucasin in Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 26, 2020 , ... Mediaplanet is proud to announce ... healthcare providers, advocates, and scientists to spread awareness of chronic lung disease as ... conditions. , More than 35 million Americans live with a chronic ...
(Date:6/25/2020)... ... June 25, 2020 , ... Billon Group ... build a distributed ledger platform to store COVID-19 related certificates to support workers’ ... a fully functioning prototype for publishing, sharing and verifying a wide array of ...
(Date:6/25/2020)... ... June 25, 2020 , ... The Heritage Downtown Active Senior ... cases of COVID-19. With over 100,000 positive cases of the coronavirus in the United ... who reside at The Heritage Downtown, their family members, as well as the Walnut ...
Breaking Medicine Technology:
(Date:7/10/2020)... ... July 10, 2020 , ... 3Lions ... our Business Partner Vetting (BPV) Portal . Expresso® 3.0 contains a Portal ... No more manually mailing, tracking, and performing other administrative tasks that amount ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... featured in Biocompare’s latest content hub— Future Lab: COVID-19 R&D . , ... advancements, trends, news, and products within specific scientific niches. Since their launch four ...
(Date:7/2/2020)... Ala. (PRWEB) , ... July 02, 2020 , ... ... awarded its annual Outstanding Safety Professional of the Year Award to Eric Simmons ... Simmons from more than 250 nominations. Simmons, who holds a master’s degree in ...
(Date:7/1/2020)... ... 01, 2020 , ... Psilera Bioscience (“Psilera”), a ... announces its core executive team. The co-founders Drs. Jackie Salm and Chris Witowski ... as distinguished researchers within the cannabis industry. They are joined by pharmaceutical and ...
(Date:6/28/2020)... ... 2020 , ... PathAI, a global provider of artificial intelligence (AI)-powered technology for ... scoring of PD-L1 expression to assess response in patients treated with Bristol Myers Squibb’s ... for Cancer Research (AACR) Annual Meeting. AACR was held June 22 to June 24. ...
Breaking Medicine News(10 mins):